Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to BREAST CANCER

The New England Journal of Medicine

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Oncology, Medical January 23rd 2023

Cancer Therapy Advisor

Distinguishing HER2-Negative From HER2-Low Breast Cancer

Oncology, Medical January 17th 2023

MedPage Today

RT After Breast-Conserving Surgery Shows No Survival Advantage Decades Later

Oncology, Medical November 28th 2022

The New England Journal of Medicine

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Oncology, Medical November 14th 2022

JAMA Network

Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients with Advanced-Stage ERBB2-Positive Breast Cancer: A Phase 1 Nonrandomized Clinical Trial

Oncology, Medical November 7th 2022

Cancer Therapy Advisor

Cancer Treatment Regimens

Oncology, Medical October 7th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form